---
layout: post
title: "Prospective Grant of an Exclusive Patent License: Size-Dependent Brain and Lymphatic Distribution of Macromolecular Drug Delivery Platform"
date: 2026-02-04 21:51:33 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-06878
original_published: 2025-04-22 00:00:00 +0000
significance: 8.00
---

# Prospective Grant of an Exclusive Patent License: Size-Dependent Brain and Lymphatic Distribution of Macromolecular Drug Delivery Platform

**Published:** February 04, 2026 21:51 UTC
**Source:** Federal Register
**Original Published:** April 22, 2025 00:00 UTC
**Document Number:** 2025-06878

## Summary

The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents applications listed in the Supplementary Information section of this notice to Sangam Lifesciences, Inc. (Sangam), a company located in Denver, Colorado.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/04/22/2025-06878/prospective-grant-of-an-exclusive-patent-license-size-dependent-brain-and-lymphatic-distribution-of)
- API: https://www.federalregister.gov/api/v1/documents/2025-06878

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
